| Nr. | Year OPEN | Title | users say> | rate good | rate bad | no link | Citation |
Drug deliverySonopheresisBlood brain barrierNanomedicineAntibodies (Immunochemistry)Natural productsRedox (BASKET)Antioxidants| 1 | 2006 | Protein transduction technology: a novel therapeutic perspective. | 
| + | - | nl | Acta Med Okayama 60(1):1-11 (2006) |
| 2 | 2010 | Macromolecular drug transport into the brain using targeted therapy. | 
| + | - | nl | J Neurochem 113(1):1-13 (2010) |
| 3 | 1991 | Utilizing vascular prostheses for drug delivery. | 
| + | - | nl | J Vasc Surg 13(5):753-5 (1991) |
| 4 | 2008 | Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy. | 
| + | - | nl | Pharmacol Rev 60(2):196-209 (2008) |
| 5 | 2002 | Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway. | 
| + | - | nl | Pharmacol Rev 54(4):561-87 (2002) |
| 6 | 2009 | The use of sonophoresis in the administration of drugs throughout the skin. | 
| + | - | nl | J Pharm Pharm Sci 12(1):88-115 (2009) |
| 7 | 2003 | Drug delivery to the central nervous system: a review. | 
| + | - | nl | J Pharm Pharm Sci 6(2):252-73 (2003) |
| 8 | 2010 | Recent advances in transdermal drug delivery. | 
| + | - | nl | Arch Pharm Res 33(3):339-51 (2010) |
| 9 | 2002 | Recent progress in drug delivery systems for anticancer agents. | 
| + | - | nl | Arch Pharm Res 25(3):229-39 (2002) |
| 10 | 2005 | Development of cell-specific targeting systems for drugs and genes. | 
| + | - | nl | Biol Pharm Bull 28(2):195-200 (2005) |
| 11 | 2007 | Physical mechanisms and methods employed in drug delivery to tumors. | 
| + | - | nl | Acta Pharm 57(3):249-68 (2007) |
| 12 | 2008 | Tumor targeting using liposomal antineoplastic drugs. | 
| + | - | nl | Int J Nanomedicine 3(1):21-9 (2008) |
| 13 | 2008 | Recent advances in ceramic implants as drug delivery systems for biomedical applications. | 
| + | - | nl | Int J Nanomedicine 3(4):403-14 (2008) |
| 14 | 2007 | Perspectives on transdermal ultrasound mediated drug delivery. | 
| + | - | nl | Int J Nanomedicine 2(4):585-94 (2007) |
| 15 | 2009 | Intranasal drug delivery: how, why and what for? | 
| + | - | nl | J Pharm Pharm Sci 12(3):288-311 (2009) |
| 16 | 2005 | Micellar solubilization of drugs. | 
| + | - | nl | J Pharm Pharm Sci 8(2):147-65 (2005) |
| 17 | 2003 | Development of liposomal polyene antibiotics: an historical perspective. | 
| + | - | nl | J Pharm Pharm Sci 6(1):67-83 (2003) |
| 18 | 1998 | Drug uptake from the airways and lungs. | 
| + | - | nl | Indian J Physiol Pharmacol 42(1):3-14 (1998) |
| 19 | 2007 | Antibody constructs in cancer therapy: protein engineering strategies to improve exposure in solid tumors. | 
| + | - | nl | Cancer 109(2):170-9 (2007) |
| 20 | 2005 | Liposomal, nanoparticle, and conjugated formulations of anticancer agents. | 
| + | - | nl | Clin Cancer Res 11(23):8230-4 (2005) |
| 21 | 2004 | Targeting of radio-isotopes for cancer therapy. | 
| + | - | nl | Cancer Biol Ther 3(4):361-70 (2004) |
| 22 | 2010 | Ocular drug delivery. | 
| + | - | nl | AAPS J 12(3):348-60 (2010) |
| 23 | 2006 | CNS drug delivery: opioid peptides and the blood-brain barrier. | 
| + | - | nl | AAPS J 8(1):E76-88 (2006) |
| 24 | 2007 | Varying polymer architecture to deliver drugs. | 
| + | - | nl | AAPS J 9(2):E235-40 (2007) |
| 25 | 2008 | Topical ocular delivery of NSAIDs. | 
| + | - | nl | AAPS J 10(2):229-41 (2008) |
| 26 | 2009 | Delivery of macromolecules using arginine-rich cell-penetrating peptides: ways to overcome endosomal entrapment. | 
| + | - | nl | AAPS J 11(1):13-22 (2009) |
| 27 | 2006 | Issues related to targeted delivery of proteins and peptides. | 
| + | - | nl | AAPS J 8(3):E466-78 (2006) |
| 28 | 2008 | Percutaneous permeation enhancement by terpenes: mechanistic view. | 
| + | - | nl | AAPS J 10(1):120-32 (2008) |
| 29 | 2008 | Prodrug approaches for CNS delivery. | 
| + | - | nl | AAPS J 10(1):92-102 (2008) |
| 30 | 2002 | Peptide delivery to the brain via adsorptive-mediated endocytosis: advances with SynB vectors. | 
| + | - | nl | AAPS PharmSci 4(4):E26 (2002) |
| 31 | 2010 | Application of in situ polymerization for design and development of oral drug delivery systems. | 
| + | - | nl | AAPS PharmSciTech 11(4):1603-11 (2010) |
| 32 | 2010 | Injectable lipid emulsions-advancements, opportunities and challenges. | 
| + | - | nl | AAPS PharmSciTech 11(4):1526-40 (2010) |
| 33 | 2005 | Cyclodextrins in drug delivery: an updated review. | 
| + | - | nl | AAPS PharmSciTech 6(2):E329-57 (2005) |
| 34 | 2005 | Floating drug delivery systems: a review. | 
| + | - | nl | AAPS PharmSciTech 6(3):E372-90 (2005) |
| 35 | 2005 | Lecithin organogels as a potential phospholipid-structured system for topical drug delivery: a review. | 
| + | - | nl | AAPS PharmSciTech 6(2):E298-310 (2005) |
| 36 | 2009 | Organic-inorganic composites for bone drug delivery. | 
| + | - | nl | AAPS PharmSciTech 10(4):1158-71 (2009) |
| 37 | 2009 | Dental mold: a novel formulation to treat common dental disorders. | 
| + | - | nl | AAPS PharmSciTech 10(2):692-702 (2009) |
| 38 | 2008 | Exemestane loaded self-microemulsifying drug delivery system (SMEDDS): development and optimization. | 
| + | - | nl | AAPS PharmSciTech 9(2):628-34 (2008) |
| 39 | 2008 | Design and evaluation of self-emulsifying drug delivery systems (SEDDS) of nimodipine. | 
| + | - | nl | AAPS PharmSciTech 9(1):191-6 (2008) |
| 40 | 2010 | Chronopharmaceutical drug delivery systems: Hurdles, hype or hope? | 
| + | - | nl | Adv Drug Deliv Rev 62(9-10):898-903 (2010) |
| 41 | 2010 | Platelets as delivery systems for disease treatments. | 
| + | - | nl | Adv Drug Deliv Rev 62(12):1196-203 (2010) |
| 42 | 2009 | Mathematical modeling of molecular diffusion through mucus. | 
| + | - | nl | Adv Drug Deliv Rev 61(2):101-14 (2009) |
| 43 | 2007 | Endocytic mechanisms for targeted drug delivery. | 
| + | - | nl | Adv Drug Deliv Rev 59(8):748-58 (2007) |
| 44 | 2007 | Delivery of drugs and macromolecules to mitochondria. | 
| + | - | nl | Adv Drug Deliv Rev 59(8):729-38 (2007) |
| 45 | 2007 | Alternate routes for drug delivery to the cell interior: pathways to the Golgi apparatus and endoplasmic reticulum. | 
| + | - | nl | Adv Drug Deliv Rev 59(8):782-97 (2007) |
| 46 | 2007 | Biodegradable nanoparticles for cytosolic delivery of therapeutics. | 
| + | - | nl | Adv Drug Deliv Rev 59(8):718-28 (2007) |
| 47 | 2009 | Mucus-penetrating nanoparticles for drug and gene delivery to mucosal tissues. | 
| + | - | nl | Adv Drug Deliv Rev 61(2):158-71 (2009) |
| 48 | 2008 | The chemistry of irreversible capture. | 
| + | - | nl | Adv Drug Deliv Rev 60(12):1383-8 (2008) |
| 49 | 2008 | The design of guanidinium-rich transporters and their internalization mechanisms. | 
| + | - | nl | Adv Drug Deliv Rev 60(4-5):452-72 (2008) |
| 50 | 2008 | Ultrasound for drug and gene delivery to the brain. | 
| + | - | nl | Adv Drug Deliv Rev 60(10):1209-17 (2008) |
| 51 | 2008 | Micelles and nanoparticles for ultrasonic drug and gene delivery. | 
| + | - | nl | Adv Drug Deliv Rev 60(10):1137-52 (2008) |
| 52 | 2008 | Microbubbles in ultrasound-triggered drug and gene delivery. | 
| + | - | nl | Adv Drug Deliv Rev 60(10):1153-66 (2008) |
| 53 | 2008 | Ultrasound mediated delivery of drugs and genes to solid tumors. | 
| + | - | nl | Adv Drug Deliv Rev 60(10):1193-208 (2008) |
| 54 | 2008 | Porous silicon in drug delivery devices and materials. | 
| + | - | nl | Adv Drug Deliv Rev 60(11):1266-77 (2008) |
| 55 | 2010 | Beyond oncology--application of HPMA copolymers in non-cancerous diseases. | 
| + | - | nl | Adv Drug Deliv Rev 62(2):258-71 (2010) |
| 56 | 2009 | Self-assembling materials for therapeutic delivery. | 
| + | - | nl | Acta Biomater 5(3):817-31 (2009) |
| 57 | 2010 | Chitosan based polyelectrolyte complexes as potential carrier materials in drug delivery systems. | 
| + | - | nl | Mar Drugs 8(4):1305-22 (2010) |
| 58 | 2010 | Chitin and chitosan as multipurpose natural polymers for groundwater arsenic removal and AS2O3 delivery in tumor therapy. | 
| + | - | nl | Mar Drugs 8(5):1518-25 (2010) |
| 59 | 2002 | Pressurised metered-dose inhalers (MDIs) versus dry powder inhalers devices (DPIs) to rapid-acting inhaled b2-agonists for asthma in children. | 
| + | - | nl | Allergol Immunopathol (Madr) 30(4):245-9 (2002) |
| 60 | 2010 | Targeted drug delivery in pancreatic cancer. | 
| + | - | nl | Biochim Biophys Acta 1805(1):97-104 (2010) |
| 61 | 2010 | Cyclotides, a promising molecular scaffold for peptide-based therapeutics. | 
| + | - | nl | Biopolymers 94(5):611-6 (2010) |
| 62 | 2009 | How do poly lactide-co-glycolide microspheres for prostaglandin E1 operate in ischemic tissue? Local sustained release of prostaglandin E1 induces neovascularization in murine hindlimb ischemia. | 
| + | - | nl | Circ J 73(7):1201-2 (2009) |
| 63 | 2007 | 'Magic bullets' for bone diseases: progress in rational design of bone-seeking medicinal agents. | 
| + | - | nl | Chem Soc Rev 36(3):507-31 (2007) |
| 64 | 2011 | Mitochondria-targeted antioxidants as therapies. | 
| + | - | nl | Discov Med 11(57):106-14 (2011) |
| 65 | 2008 | Cell penetrating peptide inhibitors of nuclear factor-kappa B. | 
| + | - | nl | Cell Mol Life Sci 65(22):3564-91 (2008) |
| 66 | 2010 | Targeting of drugs and nanoparticles to tumors. | 
| + | - | nl | J Cell Biol 188(6):759-68 (2010) |
| 67 | 2009 | Modular nanotransporters of anticancer drugs conferring cell specificity and higher efficiency. | 
| + | - | nl | Biochemistry (Mosc) 74(13):1567-74 (2009) |
| 68 | 2009 | Novel technologies for antiangiogenic drug delivery in the brain. | 
| + | - | nl | Cell Adh Migr 3(2):224-9 (2009) |
| 69 | 2008 | Concept and clinical evaluation of carrier-mediated anticancer agents. | 
| + | - | nl | Oncologist 13(3):248-60 (2008) |